T. Rowe Price Associates’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,410
| Closed | -$117K | – | 2973 |
|
|
2021
Q3 | $117K | Hold |
5,410
| – | – | ﹤0.01% | 2812 |
|
|
2021
Q2 | $189K | Sell |
5,410
-52,483
| -91% | -$1.83M | ﹤0.01% | 2733 |
|
|
2021
Q1 | $5.71M | Sell |
57,893
-107,850
| -65% | -$10.6M | ﹤0.01% | 1452 |
|
|
2020
Q4 | $18M | Buy |
165,743
+60,230
| +57% | +$6.53M | ﹤0.01% | 1243 |
|
|
2020
Q3 | $10.9M | Sell |
105,513
-106,952
| -50% | -$11M | ﹤0.01% | 1282 |
|
|
2020
Q2 | $44.4M | Sell |
212,465
-32,872
| -13% | -$6.86M | 0.01% | 884 |
|
|
2020
Q1 | $24M | Buy |
245,337
+120,158
| +96% | +$11.7M | ﹤0.01% | 1011 |
|
|
2019
Q4 | $14.4M | Buy |
125,179
+20,569
| +20% | +$2.37M | ﹤0.01% | 1248 |
|
|
2019
Q3 | $5.7M | Buy |
104,610
+48,806
| +87% | +$2.66M | ﹤0.01% | 1365 |
|
|
2019
Q2 | $6.64M | Buy |
+55,804
| New | +$6.64M | ﹤0.01% | 1362 |
|
|
2015
Q2 | – | Sell |
-52,658
| Closed | -$21.3M | – | 2535 |
|
|
2015
Q1 | $21.3M | Sell |
52,658
-49,887
| -49% | -$20.2M | ﹤0.01% | 1107 |
|
|
2014
Q4 | $53.7M | Sell |
102,545
-730
| -0.7% | -$382K | 0.01% | 814 |
|
|
2014
Q3 | $34.2M | Buy |
+103,275
| New | +$34.2M | 0.01% | 954 |
|